Piper Sandler lowered the firm’s price target on Neogen to $17 from $19 following the company’s earnings release. The firm keeps a Neutral rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NEOG:
- Neogen CEO buys $284K in common stock, CFO buys $156K in common stock
- Neogen sees FY24 free cash flow (75M) vs. prior view of ‘about flat’
- Options Volatility and Implied Earnings Moves Today, April 09, 2024
- Neogen Announces Third-Quarter 2024 Results
- Neogen cuts FY24 revenue view to $910M-$920M from $935M-$955M